Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nuvo Pharmaceuticals Inc MRVFF

Nuvo Pharmaceuticals Inc is a Canadian focused healthcare company doing business as Miravo Healthcare with global reach and a diversified portfolio of commercial products. Its product targets several therapeutic areas, including pain, allergy, and dermatology. The company's strategy is to in-license and acquire growth-oriented, complementary products for Canadian and international markets.


OTCQX:MRVFF - Post by User

Bullboard Posts
Post by blackascanbeon Mar 14, 2012 1:20pm
287 Views
Post# 19669042

it does say 4 week moving average

it does say 4 week moving average

so if the week ending Feb 17 showed prescriptions up 100% from the average weekly scripts in the 4th quarter, and in the 4th quarter they filled 47,000 prescriptions, that is 3916 per week. That means that for the week ending Feb 17th they filled about 8,000 scripts. If that remained constant that would equal 416,000 scripts for the year. At approximately $130.00 per script I get about $ 55 million in sales. what would Nuvo get of that 55 million i'm not sure any guesses?? 

Bullboard Posts